Attached files
| file | filename |
|---|---|
| EX-10.1 - MANUFACTURING SUPPLY AGREEMENT - ScripsAmerica, Inc. | scrips_8ka2-ex1001.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
AMENDMENT NO. 2
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2014
SCRIPSAMERICA, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-54550 | 26-2598594 | ||
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
Corporate Office Centre Tysons II, 1650 Tysons Boulevard, Suite 1580, Tysons Corner, VA 22102
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (800) 957-7622
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SPECIAL NOTE:
The Registrant is amending its Current Report on Form 8-K, dated June 6, 2014, which was originally filed on June 9, 2014, and amended on August 1, 2014, solely for the purpose of filing the Manufacturing & Supply Agreement to include previously redacted material. No other changes to the Manufacturing & Supply Agreement or the prior filings are being made.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Exhibit Description | |
| 10.1 | Manufacturing and Supply Agreement dated as of March 11, 2014 (portions of this exhibit have been omitted pursuant to a request for confidential treatment.) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SCRIPSAMERICA, INC. | ||
| Date: August 14, 2014 | By: | /s/ Robert Schneiderman |
| Robert Schneiderman | ||
| Chief Executive Officer | ||
| 2 |